SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 28.1 EUR 1.59%
Market Cap: 4.2B EUR
Have any thoughts about
SCHOTT Pharma AG & Co KgaA?
Write Note

SCHOTT Pharma AG & Co KgaA
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SCHOTT Pharma AG & Co KgaA
Net Income (Common) Peer Comparison

Comparables:
E
EVT
GXI

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Net Income (Common)
€151.8m
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Evotec SE
XETRA:EVT
Net Income (Common)
-€170.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-21%
Gerresheimer AG
XETRA:GXI
Net Income (Common)
€115.1m
CAGR 3-Years
7%
CAGR 5-Years
-11%
CAGR 10-Years
5%

See Also

What is SCHOTT Pharma AG & Co KgaA's Net Income (Common)?
Net Income (Common)
151.8m EUR

Based on the financial report for Sep 30, 2023, SCHOTT Pharma AG & Co KgaA's Net Income (Common) amounts to 151.8m EUR.

What is SCHOTT Pharma AG & Co KgaA's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
25%

Over the last year, the Net Income (Common) growth was 21%. The average annual Net Income (Common) growth rates for SCHOTT Pharma AG & Co KgaA have been 25% over the past three years .

Back to Top